CASC9 and breast cancer: ESCCAL‐1, also called CASC9, was proved to facilitate the malignancy of CRC, EC, BC, lung cancer, glioma, ovarian cancer, and gastric cancer (GC).33, 34, 35, 36, 37, 38, 39, 40, 41